ArticleSignal transduction and targeted therapy2026
Targeting tumor-specific T cells with LAG3-directed interleukin-2 prevents T-cell exhaustion and reinvigorates antitumor immunity.
Xiaohong Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.